Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Innoviva Inc (INVA)

Innoviva Inc (INVA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,024,098
  • Shares Outstanding, K 62,445
  • Annual Sales, $ 310,460 K
  • Annual Income, $ 179,720 K
  • 60-Month Beta 0.58
  • Price/Sales 3.26
  • Price/Cash Flow 4.63
  • Price/Book 1.45
Trade INVA with:

Options Overview Details

View History
  • Implied Volatility 85.92% ( +8.90%)
  • Historical Volatility 16.96%
  • IV Percentile 99%
  • IV Rank 96.99%
  • IV High 88.25% on 10/27/23
  • IV Low 10.68% on 10/02/23
  • Put/Call Vol Ratio 0.00
  • Today's Volume 2
  • Volume Avg (30-Day) 7
  • Put/Call OI Ratio 0.48
  • Today's Open Interest 708
  • Open Int (30-Day) 1,502

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year 0.08
  • Growth Rate Est. (year over year) +1,248,650.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
15.20 +7.89%
on 05/29/24
16.50 -0.58%
on 06/18/24
+0.86 (+5.53%)
since 05/28/24
3-Month
14.32 +14.49%
on 04/16/24
16.52 -0.73%
on 05/14/24
+1.16 (+7.61%)
since 03/28/24
52-Week
12.22 +34.21%
on 11/01/23
16.86 -2.76%
on 01/04/24
+3.77 (+29.85%)
since 06/28/23

Most Recent Stories

More News
Innoviva: Q1 Earnings Snapshot

Innoviva: Q1 Earnings Snapshot

INVA : 16.40 (+1.23%)
Innoviva: Q4 Earnings Snapshot

Innoviva: Q4 Earnings Snapshot

INVA : 16.40 (+1.23%)
Chart of the Day: Innoviva - Individual Investor Favorite

The Chart of the Day belongs to the biopharma company Innoviva (INVA) . I found the stock by using Barchart's powerful screening functions to find stocks with the highest technical buy signals, highest...

INVA : 16.40 (+1.23%)
Innoviva: Q3 Earnings Snapshot

Innoviva: Q3 Earnings Snapshot

INVA : 16.40 (+1.23%)
Innoviva: Q2 Earnings Snapshot

Innoviva: Q2 Earnings Snapshot

INVA : 16.40 (+1.23%)
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Is Investigating Innoviva, Inc. for Potential Breaches of Fiduciary Duty By Its Board of Directors

/PRNewswire/ -- Purcell & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of...

INVA : 16.40 (+1.23%)
Armata Pharmaceuticals Announces New Financing and Leadership Transition to Accelerate Novel Bacteriophage Therapeutics

/PRNewswire/ -- Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a biotechnology company focused on pathogen‐specific...

INVA : 16.40 (+1.23%)
Innoviva: Q1 Earnings Snapshot

Innoviva: Q1 Earnings Snapshot

INVA : 16.40 (+1.23%)
Innoviva Announces Retirement of Board Chairman

Innoviva, Inc. (NASDAQ: INVA) (“Innoviva” and “the Company”) and George Bickerstaff, III, Chairman of the Board of Directors of the Company (the “Board”) today announced that Mr. Bickerstaff...

INVA : 16.40 (+1.23%)
Markets Today: Stock Index Futures Climb as China’s Economy Strengthens

Morning Markets June S&P 500 futures (ESM2 3) this morning are up +0.49% at a 2-month high, and June Nasdaq 100 E-Mini futures (NQM2 3) are up +0.79% at a 2-week high. U.S. stock index futures this morning...

ESU24 : 5,521.50s (-0.44%)
NQU24 : 19,927.25s (-0.56%)
BAC : 39.77 (+1.32%)
BK : 59.89 (+0.59%)
NVDA : 123.54 (-0.36%)
JNJ : 146.16 (+0.25%)
CVS : 59.06 (+1.20%)
CB : 255.08 (-2.65%)
BRO : 89.41 (-0.83%)
BLU : 14.74 (unch)
INVA : 16.40 (+1.23%)
GS : 452.32 (+1.43%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Innoviva, Inc. is focused on the development, commercialization and financial management of bio-pharmaceuticals. The company's portfolio of respiratory assets partnered with Glaxo Group Limited, including RELVAR(R)/BREO(R) ELLIPTA(R) and ANORO(R) ELLIPTA(R). Innoviva, Inc., formerly known as Theravance,...

See More

Key Turning Points

3rd Resistance Point 16.83
2nd Resistance Point 16.61
1st Resistance Point 16.51
Last Price 16.40
1st Support Level 16.19
2nd Support Level 15.97
3rd Support Level 15.87

See More

52-Week High 16.86
Last Price 16.40
Fibonacci 61.8% 15.09
Fibonacci 50% 14.54
Fibonacci 38.2% 13.99
52-Week Low 12.22

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar